Mizolastine structure, CAS 108612-45-9

Mizolastine

CAS Number108612-45-9

SynonymsMizolastine

Molecular FormulaC24H25FN6O

Molecular Weight432.49

Purity98%

Density1.3±0.1 g/cm3

Boiling Point

Melting Point217°

Flash Point

Appearancesolid

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9011475 Purity: 98%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 108612-45-9 ] Purity: 98% SDS Specification MoL

Chemical & Physical Properties
CAS Number108612-45-9
Catalog No.2A-9011475
Chinese Name咪唑斯汀
SynonymsMizolastine
Molecular FormulaC24H25FN6O
Molecular Weight432.49
Purity98
Density1.3±0.1 g/cm3
Melting Point217°
Appearancesolid
Water SolubilitySoluble in: methanol
Storage ConditionRoom Temperature
ApplicationMizolastine is a histamine H1 receptor antagonist with an IC50 of 47 nM.
HTC2933990090
PubChem ID329794852
MDL NumberMFCD00864625
SMILESFC1=CC=C(C=C1)CN2C(N(CC3)CCC3N(C)C(N4)=NC=CC4=O)=NC5=C2C=CC=C5
InChI1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32)
InChI KeyPVLJETXTTWAYEW-UHFFFAOYSA-N
NACRES CodeNA.21
UNSPSC12352200
MSDSmsds/11475_1_108612_45_9.pdf
BioactivityMizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. Target: Histamine H1-receptorMizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.Mizolastine has demonstrated antiallergic effects in animals and healthy volunteers and anti-inflammatory activity in animal models. Double-blind trials have shown mizolastine to be significantly more effective than placebo and as effective as other second generation antihistamine agents, such as loratadine or cetirizine, in the management of patients with perennial or seasonal allergic rhinitis and in patients with chronic idiopathic urticaria. Available data also suggest that prophylactic administration of mizolastine is significantly more effective than placebo and as effective as prophylactic terfenadine in delaying the onset of symptoms of seasonal allergic rhinitis. Related Catalog Signaling Pathways >> GPCR/G Protein >> Histamine Receptor Signaling Pathways >> Immunology/Inflammation >> Histamine Receptor Research Areas >> Inflammation/Immunology References [1]. Prakash A, et al. Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria. BioDrugs. 1998 Jul;10(1):41-63. Chemical & Physical Properties Density 1.3±0.1 g/cm3 Melting Point 217° Molecular Formula C24H25FN6O Molecular Weight 432.493 Exact Mass 432.207397 PSA 70.05000 LogP 3.42 Index of Refraction 1.682 InChIKey PVLJETXTTWAYEW-UHFFFAOYSA-N SMILES CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1
Use ofMizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. Target: Histamine H1-receptorMizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.Mizolastine has demonstrated antiallergic effects in animals and healthy volunteers and anti-inflammatory activity in animal models. Double-blind trials have shown mizolastine to be significantly more effective than placebo and as effective as other second generation antihistamine agents, such as loratadine or cetirizine, in the management of patients with perennial or seasonal allergic rhinitis and in patients with chronic idiopathic urticaria. Available data also suggest that prophylactic administration of mizolastine is significantly more effective than placebo and as effective as prophylactic terfenadine in delaying the onset of symptoms of seasonal allergic rhinitis. Properties Name 2-((1-(1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)piperidin-4-yl)(methyl)amino)pyrimidin-4(1H)-one Synonym More Synonyms Mizolastine Biological Activity Description Mizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. Target: Histamine H1-receptorMizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.Mizolastine has demonstrated antiallergic effects in animals and healthy volunteers and anti-inflammatory activity in animal models. Double-blind trials have shown mizolastine to be significantly more effective than placebo and as effective as other second generation antihistamine agents, such as loratadine or cetirizine, in the management of patients with perennial or seasonal allergic rhinitis and in patients with chronic idiopathic urticaria. Available data also suggest that prophylactic administration of mizolastine is significantly more effective than placebo and as effective as prophylactic terfenadine in delaying the onset of symptoms of seasonal allergic rhinitis. Related Catalog Signaling Pathways >> GPCR/G Protein >> Histamine Receptor Signaling Pathways >> Immunology/Inflammation >> Histamine Receptor Research Areas >> Inflammation/Immunology References [1]. Prakash A, et al. Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria. BioDrugs. 1998 Jul;10(1):41-63. Chemical & Physical Properties Molecular Formula C24H25FN6O Exact Mass 432.207397 PSA 70.05000 Index of Refraction 1.682 InChIKey PVLJETXTTWAYEW-UHFFFAOYSA-N
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Related Products in Specialty Chemicals
Mitoxantrone65271-80-92A-9011470
Mitoxantrone hydrochloride70476-82-32A-9011471
Mitozolomide85622-95-32A-9011472
Mivobulin122332-18-72A-9011473
Mixidine27737-38-82A-9011474
Mizoribine50524-49-72A-9011476
Mobenakin124146-64-12A-9011477
Moclobemide71320-77-92A-9011478
Moctamide29619-86-12A-9011479
Modecainide81329-71-72A-9011480
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA